Search research articles
Contact Us
Filters
Showing results (111-120 of 198) with videos related to
Page
of 20
Sort By:
Journal of Internal Medicine
|
June 1, 1989
The development of AIDS or AIDS-related conditions in a cohort of HIV antibody-positive homosexual men during a 3-year follow-up period
C Pedersen, P Kolby, J Sindrup, et al.
AIDS (London, England)
|
October 9, 1998
The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection
A Cozzi Lepri, T L Katzenstein, H Ullum, et al.
Scandinavian Journal of Immunology
|
September 14, 2001
T-cell mean telomere lengths changes in treatment naïve HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART
H Aladdin, M Von Essen, P Schjerling, et al.
Scandinavian Journal of Immunology
|
March 1, 1984
The prognosis of asymptomatic homosexual men with decreased T-helper to T-suppressor ratio
J Gerstoft, E Dickmeiss, K Bentsen, et al.
Scandinavian Journal of Infectious Diseases
|
August 26, 2000
Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels
H Ullum, A C Lepri, T L Katzenstein, et al.
Annals of Internal Medicine
|
July 6, 2000
Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis
T L Katzenstein, E Dickmeiss, H Aladdin, et al.
Scandinavian Journal of Infectious Diseases
|
October 24, 2001
HIV-1 subtypes in Denmark
R Machuca, M Bøgh, M Salminen, et al.
Scandinavian Journal of Immunology
|
May 13, 1999
Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment
H Ullum, T Katzenstein, H Aladdin, et al.
HIV Medicine
|
December 12, 2001
Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort
O Kirk, J Gerstoft, C Pedersen, et al.
Hepatology (Baltimore, Md.)
|
January 1, 1987
The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers
K Krogsgaard, B O Lindhardt, J O Nielson, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 198) with videos related to
Sort By:
Page
of 20
Journal of Internal Medicine
|
June 1, 1989
The development of AIDS or AIDS-related conditions in a cohort of HIV antibody-positive homosexual men during a 3-year follow-up period
C Pedersen, P Kolby, J Sindrup, et al.
AIDS (London, England)
|
October 9, 1998
The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection
A Cozzi Lepri, T L Katzenstein, H Ullum, et al.
Scandinavian Journal of Immunology
|
September 14, 2001
T-cell mean telomere lengths changes in treatment naïve HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART
H Aladdin, M Von Essen, P Schjerling, et al.
Scandinavian Journal of Immunology
|
March 1, 1984
The prognosis of asymptomatic homosexual men with decreased T-helper to T-suppressor ratio
J Gerstoft, E Dickmeiss, K Bentsen, et al.
Scandinavian Journal of Infectious Diseases
|
August 26, 2000
Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels
H Ullum, A C Lepri, T L Katzenstein, et al.
Annals of Internal Medicine
|
July 6, 2000
Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis
T L Katzenstein, E Dickmeiss, H Aladdin, et al.
Scandinavian Journal of Infectious Diseases
|
October 24, 2001
HIV-1 subtypes in Denmark
R Machuca, M Bøgh, M Salminen, et al.
Scandinavian Journal of Immunology
|
May 13, 1999
Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment
H Ullum, T Katzenstein, H Aladdin, et al.
HIV Medicine
|
December 12, 2001
Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort
O Kirk, J Gerstoft, C Pedersen, et al.
Hepatology (Baltimore, Md.)
|
January 1, 1987
The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers
K Krogsgaard, B O Lindhardt, J O Nielson, et al.
Page
of 20